Description
Price: $7.99 - $6.00
(as of Sep 08, 2024 15:28:22 UTC – Details)
Medline Remedy Clinical Zinc Oxide Paste Skin Protectant Review
Product Description
The Medline Remedy Clinical Zinc Oxide Paste Skin Protectant is a specially formulated cream designed to protect skin affected by wetness, urine, or stool. It’s ideal for diaper rash and incontinence protection, providing long-lasting protection without the need for frequent re-application.
Key Features
- 17% micronized zinc oxide for breathability and a smooth, rich texture
- High level of petrolatum for long-lasting protection
- Hypoallergenic and paraben-free formula, suitable for all skin types
- Sulfate-free and CHG compatible for medical professionals
- Fortified with Remedy Nutrient Complex for enhanced support for dry and irritated skin
- Convenient squeeze tube or packets for easy application
Benefits
- Provides long-lasting protection against wetness, urine, and stool
- Reduces the need for frequent re-application, minimizing irritation
- Gentle and non-irritating, suitable for all skin types, including adults and children over 2
- Fortified with nourishing botanicals and antioxidants for enhanced skin health
- Convenient and portable, making it easy to use on-the-go
Specifications
- Item model number: MSC092542H
- UPC: 884389111171
- Manufacturer: Medline
- ASIN: B00OMFS8US
- Package Dimensions: 4.88 x 1.54 x 1.5 inches; 2 ounces
Alternatives
If you’re looking for a similar product, consider the Remedy Phytoplex Z-Guard Paste, which also offers a white petrolatum-based formulation for sealing out wetness on irritated or denuded skin.
Conclusion
The Medline Remedy Clinical Zinc Oxide Paste Skin Protectant is a reliable and effective solution for protecting skin affected by wetness, urine, or stool. With its gentle and non-irritating formula, it’s suitable for all skin types, including adults and children over 2. Whether you’re dealing with diaper rash or incontinence, this cream provides long-lasting protection and relief.
Reviews
There are no reviews yet.